C. Molta

1.7k citations

36 papers · 1.3k indexed · h-index 20

Impact in

Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology

Papers in ⓘ

Rheumatology 26
- Systemic Lupus Erythematosus Research 21
- Rheumatoid Arthritis Research and Therapies 7
Immunology 18
- Psoriasis: Treatment and Pathogenesis 10
- T-cell and B-cell Immunology 6

Co-authors: Hong Kan (8 shared papers)Deborah Robertson (6 shared papers)Ronald Pedersen (6 shared papers)B Freundlich (3 shared papers)Robert Boggs (4 shared papers)Gary Milligan (3 shared papers)Enno Christophers (2 shared papers)C.E.M. Griffiths (2 shared papers)
Journals: Annals of the Rheumatic Diseases (5 papers)Lupus (3 papers)Lupus Science & Medicine (2 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)Arthritis Research & Therapy (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

C. Molta

33 papers receiving 1.3k citations

Peers

Countries citing papers authored by C. Molta

Since Specialization

Citations

This map shows the geographic impact of C. Molta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Molta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Molta more than expected).

Fields of papers citing papers by C. Molta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Molta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Molta. The network helps show where C. Molta may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Molta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Molta Line = papers co-authored together C. Molta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial BMJ ·Wolfram Sterry, J P Ortonne, Bruce Kirkham, Olivier Brocq, Deborah Robertson, Ronald Pedersen, Joanne Estojak, C. Molta, B Freundlich	2010	186
2	The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics Journal of the European Academy of Dermatology and Venereology ·Enno Christophers, Juliet N. Barker, C.E.M. Griffiths, E. Daudén, Gary Milligan, C. Molta, Reiko Sato, Robert Boggs	2009	136
3	Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA Lupus Science & Medicine ·Christopher Collins, Maria Dall’Era, H. Kan, Cynthia Macahilig, C. Molta, V. Koscielny, David J. Chang	2016	91
4	Burden of Systemic Lupus Erythematosus on Employment and Work Productivity: Data From a Large Cohort in the Southeastern United States Arthritis Care & Research ·Cristina Drenkard, Gaobin Bao, Greg Dennis, Hong Kan, Priti Jhingran, C. Molta, S. Sam Lim	2013	76
5	Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid BioMed Research International ·Hong Kan, Xue Song, Barbara H. Johnson, Benno Bechtel, Donna O'Sullivan, C. Molta	2012	73
6	Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care Lupus ·Ian N Bruce, Murray B. Urowitz, Ronald van Vollenhoven, Cynthia Aranow, James Fettiplace, Mary Oldham, B Wilson, C. Molta, David A. Roth, David Gordon	2016	67
7	Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus Clinical Therapeutics ·Manan Shah, Sham Chaudhari, Trent P. McLaughlin, Hong Kan, Benno Bechtel, G. Dennis, C. Molta	2013	61
8	Self‐reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens Journal of the European Academy of Dermatology and Venereology ·Robert Gniadecki, Deborah Robertson, C. Molta, B Freundlich, Ron Pedersen, W. Li, Robert Boggs, Art Zbrozek	2011	59
9	The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial) Journal of Dermatological Treatment ·Robert Strohal, L. Puig, Edgardo Chouela, Tsen‐Fang Tsai, Jeffrey M. Melin, Bruce Freundlich, C. Molta, Joanne Fuiman, Ronald Pedersen, Deborah Robertson	2012	58
10	Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept British Journal of Dermatology ·J.‐P. Ortonne, Alain Taı̈eb, Anthony D. Ormerod, Deborah Robertson, J. Foehl, Ronald Pedersen, C. Molta, B Freundlich	2009	53
11	Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set Annals of the Rheumatic Diseases ·Oliver FitzGerald, Philip Helliwell, Philip J. Mease, Aizad Mumtaz, Laura C. Coates, Ronald Pedersen, Henk Nab, C. Molta	2011	51
12	Presentation of SLE in UK primary care using the Clinical Practice Research Datalink Lupus Science & Medicine ·Alison Nightingale, Julie Davidson, C. Molta, Hong Kan, Neil McHugh	2017	45
13	Efficacy and safety of continuous versus paused etanercept treatment in patients with moderate-to-severe psoriasis over 54 weeks: the CRYSTEL study Expert Review of Dermatology ·Jean‐Paul Ortonne, C.E.M. Griffiths, E. Daudén, Robert Strohal, Deborah Robertson, Ronald Pedersen, C. Molta, Bruce Freundlich	2008	44
14	Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials Arthritis & Rheumatology ·Ronald van Vollenhoven, Michelle Petri, Daniel J. Wallace, David A. Roth, C. Molta, Anne E. Hammer, Yongqiang Tang, April Thompson	2016	39
15	Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab Lupus ·David A. Roth, Alan J. Thompson, Yongqiang Tang, Anne E. Hammer, C. Molta, David Gordon	2015	39
16	Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel Lupus ·Michelle Petri, Benno Bechtel, G. Dennis, Manan Shah, Trent McLaughlin, H. Kan, C. Molta	2014	37
17	Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study Journal of Dermatological Treatment ·Enno Christophers, Siegfried Segaert, Gary Milligan, C. Molta, Robert Boggs	2012	34
18	Childhood-Onset Systemic Lupus Erythematosus: Antiphospholipid Antibodies in 37 Patients and Their First-Degree Relatives PEDIATRICS ·C. Molta, Olivier Meyer, Christine Dosquet, Marcela Montes de, Marie‐Claude Babron, F Danon, Cécile Kaplan, S. Clemenceau, Françoise Castellano, Micheline Lévy	1993	31
19	Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus Clinical Therapeutics ·Hong Kan, Saurabh Nagar, Jeetvan Patel, Daniel J. Wallace, C. Molta, David J. Chang	2016	29
20	Post-marketing Experiences with Belimumab in the Treatment of SLE Patients Rheumatic Disease Clinics of North America ·Anca Askanase, Jinoos Yazdany, C. Molta	2014	20

About C. Molta

C. Molta is a scholar working on Rheumatology, Immunology, Dermatology, Pathology and Forensic Medicine and Hepatology, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (21 papers), Psoriasis: Treatment and Pathogenesis (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Systemic Sclerosis and Related Diseases (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Dermatology and Skin Diseases (6 papers), T-cell and B-cell Immunology (6 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Rheumatology (916 citations), Immunology (888 citations), Dermatology (232 citations), Hematology (268 citations) and Radiology, Nuclear Medicine and Imaging (221 citations). C. Molta has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Hong Kan, Deborah Robertson, Ronald Pedersen, B Freundlich, Robert Boggs, Gary Milligan, Enno Christophers, C.E.M. Griffiths, E. Daudén and Olivier Brocq. Their work appears in journals such as Annals of the Rheumatic Diseases, Lupus, Lupus Science & Medicine, Journal of the European Academy of Dermatology and Venereology and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact